US DoJ summons Sun Pharma over generic drug prices
The Dollar Business Bureau India’s largest drug maker, Sun Pharma, received summons over pricing and marketing of generic drugs from the US Department of Justice on Saturday. The subpoena surfaced amidst the probe initiated by US regulators into the matter of price rise of generic drugs over the past few years. However, the pharma major stated that the move will not affect the company adversely. The antitrust division of the court had asked the US arm of Sun Pharma to submit documents disclosing its employee and corporate records and communication with its competitors. Besides Sun Pharma, Dr. Reddy’s Lab, Allegran Plc also received summons from the US regulators in the past seeking pricing details. However, the details of the products involved were not disclosed. ...
US court fines Indian textile firm $100,000
The Dollar Business Bureau Pratibha Syntex was sued on the basis that it did not pay licensing fees for software manufactured by Adobe, Microsoft, and others, gaining cost advantage in the low-margin business of apparel manufacturing A US court has asked an Indian textile company to pay $100,000 as fine for using pirated software in the production of clothing items to be sold in California. As part of the settlement, which was filed in Los Angeles Superior Court and has been approved by a judge, Indore-based textile company Pratibha Syntex has been asked to pay $100,000 in restitution within 30 days. “A settlement resolving allegations that Pratibha Syntex Ltd., a company based in India, gained an unfair competitive advantage over America-based ...
